$2.22 Billion is the total value of Slate Path Capital LP's 20 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 200.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DIA | New | SPDR DOW JONES INDL AVRG ETFput | $510,210,000 | – | 3,000,000 | +100.0% | 22.95% | – |
IWM | New | ISHARES TRput | $164,025,000 | – | 1,500,000 | +100.0% | 7.38% | – |
WAG | New | WALGREEN CO | $133,061,000 | – | 2,245,000 | +100.0% | 5.98% | – |
P | Buy | PANDORA MEDIA INC | $123,337,000 | +9.3% | 5,105,000 | +33.5% | 5.55% | +75.9% |
MPC | Buy | MARATHON PETE CORP | $87,210,000 | +130.3% | 1,030,000 | +112.4% | 3.92% | +270.8% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $66,776,000 | +76.8% | 855,000 | +43.0% | 3.00% | +184.5% |
TSO | New | TESORO CORP | $64,334,000 | – | 1,055,000 | +100.0% | 2.89% | – |
ZNGA | New | ZYNGA INCcl a | $61,560,000 | – | 22,800,000 | +100.0% | 2.77% | – |
IPXL | New | IMPAX LABORATORIES INC | $55,244,000 | – | 2,330,000 | +100.0% | 2.48% | – |
YOKU | Buy | YOUKU TUDOU INCsponsored adr | $49,370,000 | -6.2% | 2,755,000 | +24.9% | 2.22% | +51.1% |
MDCO | New | MEDICINES CO | $23,994,000 | – | 1,075,000 | +100.0% | 1.08% | – |
TPUB | New | TRIBUNE PUBG CO | $10,222,000 | – | 506,531 | +100.0% | 0.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
Stitch Fix, Inc. | February 14, 2023 | ? | ? |
Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-01-22 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
SC 13G | 2023-02-14 |
13F-HR | 2023-02-14 |
SC 13G | 2023-01-13 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.